Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

U.N. to press ahead with Iran anti-drugs fund despite executions

Published 19/03/2015, 18:29
U.N. to press ahead with Iran anti-drugs fund despite executions

By Tom Esslemont

LONDON (Thomson Reuters Foundation) - The United Nations will go ahead with a multi-million dollar funding package to tackle drug trafficking in Iran despite criticism by rights groups over the use of the death penalty for offenders, a U.N. insider said on Thursday.

Data gathered by human rights campaigners shows nearly half of 753 documented executions in Iran in 2014 were for narcotics-related offences.

In 2012, Iran seized 388 tonnes of opium, the equivalent of 72 percent of all such seizures around the world. The country shares a long border with Afghanistan, which supplies about 90 percent of the world's opium, from which heroin is made.

Funding anti-drug programmes in Iran has become a controversial issue in recent years with some countries, including Britain and Denmark, withdrawing support fearing that the money could be directly linked to arrests and executions.

"This is an extremely complex issue in which you have to confront the demand and supply side," said the U.N. staff member, who requested anonymity.

"To not confront the supply side would be like opening the gate and leaving the bull to rampage and then saying, 'Let's confront the problem'," the staffer told the Thomson Reuters Foundation.

Details of the U.N. Office on Drugs and Crime's (UNODC) five-year funding package is expected to be finalised in the coming weeks.

Last year, in a letter to human rights organisations, the executive director of UNODC, Yury Fedotov, said the agency had spent $5.5 million on combating illicit trafficking and border management in Iran between 2011 and 2014.

He said he had expressed the agency's concern over the use of capital punishment for drug trafficking crimes to the Iranian authorities.

Human Rights Watch (HRW) denounced the new proposed funding.

"The UNODC should publicly criticise Iran's flagrant and continuing violation of international law, and impose a temporary freeze or full withdrawal of support," Faraz Sanei, Iran researcher for HRW, told the Thomson Reuters Foundation.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.